|
Market Cap (2-Jul) $356,619,552 (530th) |
Close (30-Jun) $0.315 |
Volume (30-Jun) 2,012,212 |
Shortsold (19-Jun) 27,150,697 (1.86%) (138th) |
|
52w High $0.415 |
52w Low $0.223 |
P/E 7.50 |
EPS -0.03 |
IMM released this announcement to the ASX on 21 July 2021, 9:00. The announcement is marked as price sensitive, and is 2 page(s) in length and 273.73kb in size.
You can view all announcements from IMM and see how they appear on a price chart on the announcements page.
At the date of this announcement, IMM was 0.613% short sold according to ASIC data. It was ranked the 247th most shorted stock on the ASX. It is now ranked as the 138th most shorted stock on the ASX with 1.859% of total shares short sold as of the latest reported data (19 June 2025).
| Other Recent Announcements from IMM | |
|---|---|
| Application for quotation of securities - IMM | 29 June 2023, 10:09 |
| US patent granted for Efti with PD-1 pathway inhibitor | 27 June 2023, 14:37 |
| Immutep completes underwritten retail entitlement offer | 27 June 2023, 8:16 |
| Completion of Share Purchase Plan | 21 July 2021, 9:00 |
| EGM - Now to be Held as an Online Virtual Meeting | 15 July 2021, 13:10 |
| Immutep Quarterly Activities Report & Appendix 4C | 13 July 2021, 9:48 |
| US FDA & IRB approves start of ph2b head & neck cancer trial | 6 July 2021, 8:58 |
You must be logged in to post a reply.
